Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) Sees Significant Decline in Short Interest

by · The Cerbat Gem

Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ – Get Free Report) was the recipient of a large decrease in short interest during the month of September. As of September 15th, there was short interest totaling 84,256 shares, a decrease of 69.1% from the August 31st total of 272,812 shares. Based on an average trading volume of 172,085 shares, the days-to-cover ratio is presently 0.5 days. Currently, 1.3% of the company’s stock are sold short.

Creative Medical Technology Trading Down 1.9%

CELZ stock opened at $1.01 on Tuesday. The stock’s 50 day simple moving average is $1.01 and its 200 day simple moving average is $1.61. Creative Medical Technology has a 12-month low of $0.62 and a 12-month high of $6.25. The firm has a market cap of $6.66 million, a P/E ratio of -0.49 and a beta of 2.04.

Creative Medical Technology (NASDAQ:CELZ – Get Free Report) last released its quarterly earnings data on Friday, August 7th. The company reported ($0.41) EPS for the quarter, missing analysts’ consensus estimates of ($0.39) by ($0.02). On average, research analysts forecast that Creative Medical Technology will post -1.18 EPS for the current fiscal year.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on the stock. Weiss Ratings downgraded shares of Creative Medical Technology from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Thursday. Wall Street Zen upgraded Creative Medical Technology from a “sell” rating to a “hold” rating in a research note on Saturday, September 12th. Finally, Roth Capital reiterated a “buy” rating on shares of Creative Medical Technology in a research note on Thursday, August 20th. One investment analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold”.

View Our Latest Report on CELZ

Creative Medical Technology Company Profile

(Get Free Report)

Creative Medical Technology Holdings, Inc is a biotechnology company focused on developing regenerative medicine and cell-based therapies. The company’s research programs are aimed at conditions involving inflammation, autoimmune dysfunction, tissue damage and sexual health.

Its pipeline has included ImmCelz, an immunomodulatory cell-therapy platform, as well as CaverStem for erectile dysfunction, FemCelz for female sexual health, KneeCelz for knee-related conditions and StemSpine for spinal disorders.

See Also